Zelira Therapeutics Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of ZLDAF for the last semiannual is 26.82 k USD, and it's 28.02% lower compared to the previous semiannual. The net income of H2 24 is -1.62 M USD.